- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06825195
Evaluation of Fingertip Precision Pinch Force in Fibromyalgia Patients
June 25, 2025 updated by: Dilara Ekici Zincirci
Evaluation of Fingertip Precision Pinch Force During Carrying in Fibromyalgia Patients.
This study aims to evaluate the force used by fibromyalgia patients during a task compared to healthy volunteers and to evaluate its relationship with fatigue seen in these patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Fatigue is a common symptom in fibromyalgia patients and it is known that these patients have decreased muscle strength compared to healthy volunteers.
The aim of this study was to evaluate whether the minimum force to be applied during carrying is different in fibromyalgia patients compared to healthy volunteers.
Study Type
Observational
Enrollment (Actual)
108
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
İstanbul, Turkey
- Prof. Dr. Cemil Taşçıoğlu Şehir Hastanesi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Female patients with fibromyalgia diagnosis and no accompanying rheumatological disease
Description
Inclusion Criteria:
-Female patients diagnosed with fibromyalgia between the ages of 18-70
Exclusion Criteria:
- Those whose treatment has been changed in the last month
- Those with shoulder, elbow, wrist and hand diseases that may cause pain in the dominant upper extremity
- Those with carpal or cubital tunnel syndrome
- Those with a history of orthopedic surgery in the dominant extremity
- Those with uncontrolled metabolic disease
- Those with B12 deficiency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Fibromiyalgia
Fibromiyalgia Patients
|
Wrist isokinetic eccentric flexor and extensor peak Torque and fatigue will be measured at the angular velocity of 180°/s
the minimum fingertip pinch force required to hold a constant weight will be measured
|
|
Healthy Control
Healthy control group
|
Wrist isokinetic eccentric flexor and extensor peak Torque and fatigue will be measured at the angular velocity of 180°/s
the minimum fingertip pinch force required to hold a constant weight will be measured
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
minimum pinch force
Time Frame: November 2024- January 2025
|
minimum fingertip pinch force required to hold a constant weight
|
November 2024- January 2025
|
|
maximum pinch force
Time Frame: November 2024- January 2025
|
maximum fingertip pinch force required to hold a constant weight
|
November 2024- January 2025
|
|
% Minimum/maksimum pinch force
Time Frame: November 2024- January 2025
|
percentage of minimum holding force to maximum holding force
|
November 2024- January 2025
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
isokinetik muscle strength
Time Frame: November 2024- January 2025
|
Wrist isokinetic extensor and flexor peak torque at 180 degrees/sec
|
November 2024- January 2025
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 11, 2024
Primary Completion (Actual)
November 11, 2024
Study Completion (Actual)
March 14, 2025
Study Registration Dates
First Submitted
February 10, 2025
First Submitted That Met QC Criteria
February 10, 2025
First Posted (Actual)
February 13, 2025
Study Record Updates
Last Update Posted (Actual)
June 26, 2025
Last Update Submitted That Met QC Criteria
June 25, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fibromiyalgia1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.